mephenesin has been researched along with Movement Disorders in 6 studies
Mephenesin: A centrally acting muscle relaxant with a short duration of action.
1-(2-methylphenyl)glycerol : A glycerol ether in which a single 2-methylphenyl group is attached at position 1 of glycerol via an ether linkage.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
BERGER, FM | 1 |
SCHWARTZ, RP | 1 |
HUNTER, AR | 1 |
WATERFALL, JM | 1 |
WALCH, R | 1 |
HOHEISEL, HP | 1 |
WEBER, HJ | 1 |
LEHNER, FH | 1 |
Critchley, E | 1 |
Blazsó, S | 1 |
6 other studies available for mephenesin and Movement Disorders
Article | Year |
---|---|
Oral myanesin in treatment of spastic and hyperkinetic disorders.
Topics: Mephenesin; Movement Disorders; Muscle Spasticity | 1948 |
Myanesin in hyperkinetic states.
Topics: Humans; Mephenesin; Movement Disorders | 1948 |
[Treatment of spastic and extrapyramidal fixed states with Byk M I].
Topics: Basal Ganglia Diseases; Disease; Extrapyramidal Tracts; Humans; Mephenesin; Movement Disorders; Musc | 1953 |
[Experiences with 3-0-toloxy-1,2-propanediol (BYK-M 1)].
Topics: Humans; Mephenesin; Movement Disorders; Physical Therapy Modalities; Propylene Glycol; Propylene Gly | 1954 |
Clinical manifestations of essential tremor.
Topics: Adult; Aged; Amantadine; Ataxia; Chlordiazepoxide; Dihydroxyphenylalanine; Female; Humans; Male; Mep | 1972 |
[On the pharmacotherapeutic treatment of cerebral palsy. I. Treatment of movement disorders].
Topics: Cerebral Palsy; Child; Child, Preschool; Chlorpromazine; Humans; Infant; Infant, Newborn; Mephenesin | 1965 |